3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Breast Neoplasms
291
Carcinoma, Non-Small-Cell Lung
222
Neoplasms
193
Prostatic Neoplasms
158
Multiple Myeloma
138
Neoplasm Metastasis
115
Melanoma
110
Colorectal Neoplasms
107
Leukemia, Myeloid, Acute
103
Lymphoma
97
Lung Neoplasms
94
Ovarian Neoplasms
84
Squamous Cell Carcinoma of Head and Neck
75
Lymphoma, Non-Hodgkin
73
Leukemia, Lymphocytic, Chronic, B-Cell
70
Pancreatic Neoplasms
64
Triple Negative Breast Neoplasms
62
Myelodysplastic Syndromes
62
Parkinson Disease 4, Autosomal Dominant Lewy Body
59
Hematologic Neoplasms
59
Head and Neck Neoplasms
59
Recurrence
56
Glioblastoma
55
Leukemia
53
Precursor Cell Lymphoblastic Leukemia-Lymphoma
52
Sarcoma
49
Brain Neoplasms
49
Lymphoma, Large B-Cell, Diffuse
47
Carcinoma, Hepatocellular
47
Lymphoma, Follicular
45
Interventions
relacorilant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Pituitary ACTH Hypersecretion
×
1 year
×
Clear all
NCT03697109
2025-07-16
GRACE
Corcept Therapeutics
Phase 3
Completed
152 enrolled
28 charts